Kura Oncology Inc (NAS:KURA)
$ 11.04 -0.13 (-1.16%) Market Cap: 858.51 Mil Enterprise Value: 419.84 Mil PE Ratio: 0 PB Ratio: 2.03 GF Score: 42/100

Q2 2022 Kura Oncology Inc Earnings Call Transcript

Aug 03, 2022 / 08:30PM GMT
Release Date Price: $15.08 (+1.07%)
Operator

Good day, and welcome to the Kura Oncology Second Quarter 2022 Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Pete De Spain, Senior Vice President of Investor Relations. Please go ahead, sir.

Pete De Spain
Kura Oncology, Inc. - SVP of IR & Corporate Communications

Thank you, Sarah. Good afternoon and welcome to Kura Oncology's second quarter 2022 conference call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Tom Doyle, our Senior Vice President of Finance and Accounting.

Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to Kura's filings with the SEC, which are available from the SEC or on the Kura Oncology website for information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot